Peer review reports
From: Anti-scarring effects of conbercept on human Tenon’s fibroblasts: comparisons with bevacizumab
Original Submission | ||
---|---|---|
10 Sep 2022 | Submitted | Original manuscript |
8 Jan 2023 | Reviewed | Reviewer Report |
16 Jan 2023 | Reviewed | Reviewer Report |
19 Mar 2023 | Author responded | Author comments - Xun Xu |
22 Mar 2023 | Author responded | Author comments - Xun Xu |
Resubmission - Version 2 | ||
19 Mar 2023 | Submitted | Manuscript version 2 |
23 Mar 2023 | Author responded | Author comments - Xun Xu |
Resubmission - Version 3 | ||
23 Mar 2023 | Submitted | Manuscript version 3 |
6 Apr 2023 | Reviewed | Reviewer Report |
8 Apr 2023 | Reviewed | Reviewer Report |
Resubmission - Version 4 | ||
Submitted | Manuscript version 4 | |
Publishing | ||
8 Apr 2023 | Editorially accepted | |
26 Apr 2023 | Article published | 10.1186/s12886-023-02914-4 |